Clinical Trials List
2016-02-29 - 2019-02-28
Phase III
Terminated5
ICD-10M48.8X9
Other specified spondylopathies, site unspecified
ICD-9720.0
Ankylosing spondylitis
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Jiunn-Horng Chen 風濕免疫科
- 蔡嘉哲 風濕免疫科
- Po-Hao Huang 風濕免疫科
- 黃建中 風濕免疫科
- Chung-Ming Huang 風濕免疫科
- 洪偉哲 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- CHENG-HAN WU Division of Rheumatology
- CHIH-WEI YU Division of Rheumatology
- KO-JEN LI Division of Rheumatology
- 郭佑民 Division of Rheumatology
- PING-NING HSU Division of Rheumatology
- CHIEH-YU SHEN Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
320 participants
